Breast Cancer Diagnostic and Drug Technologies Market 2018 Global Market
Global Breast Cancer Diagnostic and Drug Technologies Market
Description:-
The “Global Breast Cancer Diagnostic and Drug Technologies Market 2018: Global Analysis, Industry Size, Share, Trends, Application Analysis and Growth Opportunities Forecast to 2023” report has been added to Wiseguyreports.com offerings.
Currently, there are about REDACTED million women living with cancer, globally, and the incidence is gradually increasing. In women, breast cancer is the second leading cause of cancer death. Per World Health Organization (WHO) statistics, about one-third of these cancer fatalities can be decreased through earlier detection and treatment. Early breast cancer treatment and detection have improved the five-year survival rate for women diagnosed with cancer to nearly 80%. The breast cancer diagnostic and drug technology markets include a variety of products approved for breast cancer treatment, including hormonal therapies, chemotherapeutic drugs, combinations and targeted therapies. Many side effects, adverse reactions and safety concerns have come up associated with newer, innovative drugs. Therefore, drugs with improved safety and efficacy are needed to treat breast cancer effectively.
In countries such as the United States, the chance of a woman developing breast cancer during her lifetime has increased. An estimated 522,000 women died from breast cancer globally in the year 2012. WHO estimates that more than REDACTED million new cancer cases will be diagnosed by 2030. Rising healthcare costs associated with breast cancer treatment, have left several patients either uninsured or with less meaningful coverage than they need and deserve.
The objective of the current report is to provide the readers with updated market estimates for the diagnostics and therapeutics market. This report also highlights current and future market potential for breast cancer therapeutics along with a detailed analysis of the competitive environment, pipeline drugs, blockbuster drugs and other diagnostic and therapeutic development.
Browse Sample report @ http://www.wiseguyreports.com/sample-request/3195993-breast-cancer-diagnostic-and-drug-technologies-global-markets
This report includes market estimates for breast cancer diagnostics (mammography, biopsy and companion diagnostics), therapeutics along with market share of therapeutics by drug class (HER2 inhibitors, mitotic inhibitors, anti-metabolites, aromatase inhibitors and hormone receptors), geographic market segmentation of the overall market and global market share by company with special emphasis on developed and underdeveloped geographic regions. For market estimates, data has been provided for the year 2016, as the base year, 2017 and a forecast for 2022.
Table of Content
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst’s Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Introduction
Classification of Breast Cancer by Type
Non-invasive Breast Cancers
Ductal Carcinoma Insitu (DCIS)
Lobular Carcinoma Insitu (LCIS)
Invasive Breast Cancers
Invasive (or Infiltrating) Ductal Carcinoma (IDC)
Invasive (or Infiltrating) Lobular Carcinoma (ILC)
Tubular Carcinoma (TC)
Invasive Cribriform Carcinoma
Mucinous Carcinoma
Invasive Papillary Carcinoma
Inflammatory Breast Cancer
Paget’s Disease of the Breast
Cytosarcoma Phyllodes
Metastatic Breast Cancer (MBC)
Molecular Subtypes of Breast Cancer
Luminal A
Luminal B Types
HER2 Type
HER2-Amplified
Triple-Negative Breast Cancer (TNBC) or Basal Type
Normal-Like
Causes, Indications and Risk Factors
Symptoms
Breast Cancer Staging
Epidemiology
United States Breast Cancer Incidence
Chapter 4 Breast Cancer Market Dynamics
Market Drivers
Increasing Incidence of Breast Cancer Worldwide
Focused Research and Development for Novel Drugs
High Increase in Healthcare Expenditure and Funding
Increasing Breast Cancer Screening Programs
Favorable Reimbursement for Screening and Diagnosis
Market Restraints
Pricing Pressure Experienced by Innovators
High Cost Associated with New Drug Development and Clinical Trials
Regulatory and Reimbursement Hurdles
Market Opportunity
Rising Female Population in Asia Pacific
Increased Demand for Technology Innovation
Technological Advancement in the Drug Sector
Emergence of Breast Cancer Predictive Tests
Opportunity for Generic Manufacturers to Exploit Patents at the Verge of Expiry
Breast Cancer Therapy: Unmet Needs
………….
Chapter 7 Market Breakdown by Region
Breast Cancer Incidence by Region
Global Market by Region
North America
Europe
Asia-Pacific
Middle East and Africa (MEA)
South America
Chapter 8 Regulatory Scenario
Breast Cancer Diagnostics and Therapeutics Regulatory Challenges
North America
Food and Drug Administration (FDA)
Europe
Asia-Pacific
Japan
China
South America
Brazil
Chapter 9 Patent Review/New Developments
Patent Review
Companion Diagnostics
Patent Expiration
Chapter 10 Reimbursement Landscape
Introduction
United States
Mammography Procedure Reimbursement
Biopsy Procedure Reimbursement
Breast Cancer Drugs Reimbursement
Germany
Mammography Procedure Reimbursement
Biopsy Procedure Reimbursement
Breast Cancer Drugs Reimbursement
Mexico
Brazil
Continued……….
Browse Full report @ https://www.wiseguyreports.com/reports/3195993-breast-cancer-diagnostic-and-drug-technologies-global-markets
About Us:
Wise Guy Reports Is Part Of The Wise Guy Consultants Pvt. Ltd. And Offers Premium Progressive Statistical Surveying, Market Research Reports, Analysis & Forecast Data For Industries And Governments Around The Globe. Wise Guy Reports Features An Exhaustive List Of Market Research Reports From Hundreds Of Publishers Worldwide. We Boast A Database Spanning Virtually Every Market Category And An Even More Comprehensive Collection Of Market Research Reports Under These Categories And Sub-Categories.
Contact Us:
Wise Guy Research Consultants Pvt Ltd
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Maharashtra, Pune – 411028
Posted by
Vivian Dsena
on Friday September 07 2018, 4:46 AM EST.
All trademarks acknowledged.
Filed under Uncategorized.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
